Viewing Study NCT00084318

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:35 AM
Ignite Modification Date: 2026-06-11 @ 6:37 PM
Study NCT ID: NCT00084318
Status: COMPLETED
Last Update Posted: 2018-12-12
First Post: 2004-06-10
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Sponsor: Radiation Therapy Oncology Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III squamous cell carcinoma of the hypopharynx View
None stage IV squamous cell carcinoma of the hypopharynx View
None stage III squamous cell carcinoma of the oropharynx View
None stage IV squamous cell carcinoma of the oropharynx View
None stage III squamous cell carcinoma of the larynx View
None stage IV squamous cell carcinoma of the larynx View
None stage III lymphoepithelioma of the oropharynx View
None stage IV lymphoepithelioma of the oropharynx View